4.6 Article

MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Regulation of PD-L1 expression in the tumor microenvironment

Ming Yi et al.

Summary: PD-L1 expression is regulated by various factors, impacting the treatment effect and patient selection. Understanding the mechanisms of PD-L1 regulation helps enhance the efficacy of immunotherapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Multidisciplinary Sciences

Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy

Xiaodong Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Biochemistry & Molecular Biology

MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells

Jiahuan Zou et al.

MOLECULAR IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Targeting oncogenic Myc as a strategy for cancer treatment

Hui Chen et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)

Article Multidisciplinary Sciences

MYC regulates the antitumor immune response through CD47 and PD-L1

Stephanie C. Casey et al.

SCIENCE (2016)

Article Multidisciplinary Sciences

Comprehensive genomic characterization of head and neck squamous cell carcinomas

Michael S. Lawrence et al.

NATURE (2015)

Article Biotechnology & Applied Microbiology

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

Garrett M. Frampton et al.

NATURE BIOTECHNOLOGY (2013)

Review Oncology

The c-Myc target gene network

Chi V. Dang et al.

SEMINARS IN CANCER BIOLOGY (2006)